Metformin hydrochloride
Based on 199 publication(s) in Google Scholar
Metformin (1,1-Dimethylbiguanide) hydrochloride inhibits the mitochondrial respiratory chain in the liver, leading to AMPK activation and enhancing insulin sensitivity, and can be used in the study of type 2 diabetes. Metformin hydrochloride exerts central glucose-lowering effects by inhibiting Ras-related protein 1 (Rap1) in SF1 hypothalamic neurons. Metformin hydrochloride also inhibits liver oxidative stress, nitrosative stress, inflammation, and apoptosis caused by liver ischemia/reperfusion injury. In addition, Metformin hydrochloride regulates the expression of autophagy-related proteins by activating AMPK and inhibiting the mTOR signaling pathway, thereby inducing tumor cell autophagy and inhibiting the growth of renal cell carcinoma in vitro and in vivo.
For research use only. We do not sell to patients.
- Purity: 99.98%
- CAS No.: 1115-70-4
- Formula: C4H12ClN5
- Molecular Weight:165.62
-
Storage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications Citing Use of MedChemExpress (MCE) Metformin hydrochloride
More- Signal Transduct Target Ther. 2023 Mar 6;8(1):95. [Abstract]
- Signal Transduct Target Ther. 2020 May 20;5(1):56. [Abstract]
- Nature. 2025 Feb;638(8052):1112-1121. [Abstract]
- Nature. 2023 Sep;621(7977):188-195. [Abstract]
- Cancer Cell. 2020 Sep 14;38(3):350-365.e7. [Abstract]
- Circulation. 2023 Jan 10;147(2):158-174. [Abstract]
- Cell Metab. 2023 Jul 11;35(7):1132-1146.e9. [Abstract]
- Cell Metab. 2023 Jan 3;35(1):101-117.e11. [Abstract]
- Adv Mater. 2020 Nov;32(45):e2003708. [Abstract]
- Cell Res. 2023 Dec;33(12):904-922. [Abstract]
- Nat Metab. 2025 Apr;7(4):730-741. [Abstract]
- Cell Stem Cell. 2024 Jan 4;31(1):52-70.e8. [Abstract]
- Nat Commun. 2025 Nov 28;16(1):10751. [Abstract]
- Nat Commun. 2021 Aug 24;12(1):5106. [Abstract]
- Nat Commun. 2019 Feb 6;10(1):620. [Abstract]
- Cell Death Differ. 2023 Jul;30(7):1829-1848. [Abstract]
- Bone Res. 2023 Aug 16;11(1):45. [Abstract]
- Acta Pharm Sin B. 2025 Dec;15(12):6382-6398. [Abstract]
- Autophagy. 2025 Nov 30:1-21. [Abstract]
- Adv Sci (Weinh). 2026 Apr;13(21):e13341. [Abstract]
- J Adv Res. 2025 Mar 10:S2090-1232(25)00174-2. [Abstract]
- J Adv Res. 2024 Apr 14:S2090-1232(24)00155-3. [Abstract]
- Biomaterials. 2026 Jun:329:123966. [Abstract]
- Biomaterials. 2025 Aug:319:123210. [Abstract]
- Biomaterials. 2021 Jul:274:120850. [Abstract]
- Exp Mol Med. 2019 May 22;51(5):1-14. [Abstract]
- Protein Cell. 2022 Nov;13(11):825-841. [Abstract]
- J Nanobiotechnology. 2025 Oct 14;23(1):670. [Abstract]
- Sci Adv. 2026 Jan 2;12(1):eadz9069. [Abstract]
- Sci Adv. 2025 May 16;11(20):eadq3870. [Abstract]
- Redox Biol. 2023 Aug:64:102786. [Abstract]
- Cell Rep Med. 2025 Jul 15;6(7):102211. [Abstract]
- Cancer Lett. 2026 Apr 28:644:218311. [Abstract]
- Cancer Lett. 2024 Aug 21:217177. [Abstract]
- Cancer Lett. 2024 Apr 10:587:216732. [Abstract]
- J Neuroinflammation. 2022 Jan 29;19(1):25. [Abstract]
- Cancer Lett. 2022 Apr 28:532:215582. [Abstract]
- Cell Death Dis. 2022 Apr 20;13(4):384. [Abstract]
- Cell Death Dis. 2021 Oct 9;12(10):925. [Abstract]
- Cell Death Dis. 2021 Oct 2;12(10):902. [Abstract]
- Genes Dis. 2025 Sep 10.
- Small Methods. 2020, 2000483.
- Cell Commun Signal. 2023 May 4;21(1):99. [Abstract]
- Int J Biol Macromol. 2025 Aug 21;323(Pt 1):147047. [Abstract]
- Acta Pharmacol Sin. 2022 Jun;43(6):1360-1371. [Abstract]
- Phytomedicine. 2025 Nov 27:150:157628. [Abstract]
- Phytomedicine. 2024 Jul:129:155679. [Abstract]
- Free Radic Biol Med. 2025 Sep:237:503-514. [Abstract]
- Food Res Int. 2025 Jun:211:116502. [Abstract]
- Sci Total Environ. 2024 Feb 20:912:169496. [Abstract]
- Brain Behav Immun. 2024 Jun 6:S0889-1591(24)00445-8. [Abstract]
- Biomed Pharmacother. 2024 Sep 6:179:117399. [Abstract]
- Emerg Microbes Infect. 2022 Dec;11(1):815-828. [Abstract]
- Biomed Pharmacother. 2019 Jul:115:108875. [Abstract]
- Chin Med J (Engl). 2025 Jun 16. [Abstract]
- Stem Cell Res Ther. 2025 Apr 18;16(1):186. [Abstract]
- Stem Cell Res Ther. 2025 Jan 23;16(1):20. [Abstract]
- PLoS Biol. 2025 Nov 24;23(11):e3003490. [Abstract]
- Aging Cell. 2026 Jan 20;25(2):e70352.
- Cell Rep. 2022 Nov 22;41(8):111707. [Abstract]
- Cell Rep. 2019 Oct.
- Arch Toxicol. 2019 Jun;93(6):1697-1712. [Abstract]
- J Med Chem. 2022 Sep 8;65(17):11818-11839. [Abstract]
- Anal Chem. 2025 Dec 19. [Abstract]
- Antioxidants. 2020 Oct 28;9(11):1057. [Abstract]
- Fundam Res. 2025 Dec 16.
- Phytother Res. 2024 May 10. [Abstract]
- Cell Mol Life Sci. 2023 Sep 9;80(10):283. [Abstract]
- EMBO Rep. 2022 Jun 7;23(6):e54147. [Abstract]
- Hum Reprod. 2020 May 1;35(5):1145-1158. [Abstract]
- Cancer Cell Int. 2024 Feb 14;24(1):74. [Abstract]
- Front Immunol. 2016 Dec 12:7:597. [Abstract]
- Chin Med. 2025 Nov 17;20(1):190. [Abstract]
- Biochem Pharmacol. 2023 Sep:215:115636. [Abstract]
- Biochem Pharmacol. 2017 Aug 15:138:49-60. [Abstract]
- Mol Cell Proteomics. 2017 Jul;16(7):1324-1334. [Abstract]
- J Ethnopharmacol. 2026 Feb 28:357:120941. [Abstract]
- Liver Int. 2023 Jul;43(7):1577-1592. [Abstract]
- Mech Ageing Dev. 2020 Oct;191:111347. [Abstract]
- Life Sci. 2019 Sep 1:232:116622. [Abstract]
- Biofactors. 2023 Jul-Aug;49(4):831-848. [Abstract]
- PLoS Pathog. 2024 Jun 21;20(6):e1012305. [Abstract]
- PLoS Pathog. 2023 Feb 3;19(2):e1011126. [Abstract]
- Int J Mol Sci. 2022 Dec 25;24(1):343. [Abstract]
- Biomolecules. 2025 Apr 9;15(4):556. [Abstract]
- Pharmaceuticals (Basel). 2024 Sep 19;17(9):1234. [Abstract]
- Front Bioeng Biotechnol. 2022 Mar 17;10:826093. [Abstract]
- Biomolecules. 2022 Mar 9;12(3):422. [Abstract]
- Front Pharmacol. 2020 Jul 31;11:1038. [Abstract]
- Front Pharmacol. 2016 Oct 20:7:390. [Abstract]
- Eur J Pharmacol. 2025 Sep 15:1003:177900. [Abstract]
- Int Immunopharmacol. 2025 May 20:159:114897. [Abstract]
- Am J Physiol Cell Physiol. 2024 Jun 1;326(6):C1590-C1603. [Abstract]
- Int Immunopharmacol. 2023 Sep 15;124(Pt A):110905. [Abstract]
- Eur J Pharmacol. 2023 Oct 5:956:175942. [Abstract]
- Eur J Pharmacol. 2023 Mar 15:943:175569. [Abstract]
- Cell Regen. 2022 May 5;11(1):19. [Abstract]
- Neuropharmacology. 2020 Mar 15;165:107816. [Abstract]
- Mol Oncol. 2017 Oct;11(10):1475-1492. [Abstract]
- Mol Oncol. 2017 Aug;11(8):1035-1049. [Abstract]
- Cancers (Basel). 2026 May 27;18(11):1746. [Abstract]
- Probiotics Antimicrob Proteins. 2025 Nov 26. [Abstract]
- Rheumatology (Oxford). 2023 Apr 3;62(4):1652-1661. [Abstract]
- Cancers (Basel). 2022 Mar 17;14(6):1538. [Abstract]
- Cancers (Basel). 2021 Aug 6;13(16):3978. [Abstract]
- Transl Stroke Res. 2023 Jun;14(3):364-382. [Abstract]
- Mol Neurobiol. 2017 Jul;54(5):3327-3341. [Abstract]
- J Cell Mol Med. 2019 Sep;23(9):6048-6059. [Abstract]
- J Cell Mol Med. 2017 Dec;21(12):3322-3336. [Abstract]
- iScience. 2026 Jun 13;29(7):116323. [Abstract]
- J Inflamm Res. 2026 Feb 2:19:540176. [Abstract]
- J Inflamm Res. 2025 Mar 19:18:4087-4101. [Abstract]
- iScience. 2025 Apr 3;28(5):112344. [Abstract]
- J Inflamm (Lond). 2024 Jul 9;21(1):25. [Abstract]
- iScience. 2023 Jan 25;26(4):106057. [Abstract]
- J Cell Physiol. 2025 Nov;240(11):e70110. [Abstract]
- J Drug Target. 2025 Jul 17:1-10. [Abstract]
- Sci Rep. 2025 Jul 26;15(1):27294. [Abstract]
- Sci Rep. 2025 Apr 2;15(1):11309. [Abstract]
- Biomedicines. 2024 Nov 4;12(11):2526. [Abstract]
- Aquaculture. 2024 Dec 15.
- J Biol Chem. 2020 Apr 3;295(14):4451-4463. [Abstract]
- J Virol. 2025 Aug 29:e0052925. [Abstract]
- Cell Signal. 2024 Jun:118:111125. [Abstract]
- Brain Res Bull. 2020 Nov;164:146-156. [Abstract]
- Bone. 2025 Jan 28:193:117411. [Abstract]
- Mol Cell Endocrinol. 2024 Mar 1:582:112140. [Abstract]
- Exp Cell Res. 2026 Apr 1;457(1):114922. [Abstract]
- Mol Med Rep. 2023 Jan;27(1):17. [Abstract]
- Spine. 2019 Aug 1;44(15):E865-E872. [Abstract]
- Acta Biochim Biophys Sin (Shanghai). 2021 Mar 2;53(3):333-341. [Abstract]
- Andrology. 2020 May;8(3):663-670. [Abstract]
- Appl Biochem Biotechnol. 2026 Mar 17. [Abstract]
- J Food Meas Charact. 2025 Sep 1.
- Biochim Biophys Acta Mol Cell Biol Lipids. 2025 May 12:159628. [Abstract]
- Front Oncol. 2021 Nov 22;11:762523. [Abstract]
- Pathogens. 2021 Mar 2;10(3):283. [Abstract]
- Endocrinology. 2018 May 1;159(5):2008-2021. [Abstract]
- Environ Toxicol. 2024 Apr;39(4):2452-2465. [Abstract]
- Environ Toxicol. 2021 Dec;36(12):2414-2425. [Abstract]
- Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 4. [Abstract]
- J Neuropathol Exp Neurol. 2025 Aug 19:nlaf092. [Abstract]
- Curr Issues Mol Biol. 2025 Jul 3;47(7):515. [Abstract]
- Breast Cancer Res Treat. 2025 Jun;211(2):467-478. [Abstract]
- Mol Reprod Dev. 2024 Aug;91(8):e23768. [Abstract]
- Arch Biochem Biophys. 2022 Jun 15;722:109216. [Abstract]
- Oral Dis. 2025 Feb;31(2):468-481. [Abstract]
- J Appl Toxicol. 2026 Feb 2. [Abstract]
- Neuroscience. 2025 Jan 26:565:91-98. [Abstract]
- J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Dec 28:1252:124446. [Abstract]
- J Orthop Surg Res. 2023 Nov 4;18(1):831. [Abstract]
- Genes (Basel). 2022 Dec 16;13(12):2384. [Abstract]
- Onco Targets Ther. 2020 May 4;13:3777-3788. [Abstract]
- Onco Targets Ther. 2020 May 19;13:4445-4455. [Abstract]
- Virus Res. 2023 Aug:333:199139. [Abstract]
- PLoS One. 2023 May 18;18(5):e0283943. [Abstract]
- Cell Biochem Biophys. 2025 Apr 4. [Abstract]
- Oncol Lett. 2021 Jan;21(1):31. [Abstract]
- Biochem Bioph Res Co. 2020 Dec 17;533(4):665-671. [Abstract]
- Biochem Cell Biol. 2023 Dec 1;101(6):523-530. [Abstract]
- Physiol Res. 2026 Mar 13;75(1):187-192. [Abstract]
- Stem Cells Dev. 2021 Oct 15;30(20):1017-1027. [Abstract]
- Cell Physiol Biochem. 2018;51(4):1566-1583. [Abstract]
- Cell Physiol Biochem. 2017;44(4):1381-1395. [Abstract]
- Cancer Rep (Hoboken). 2025 Jul;8(7):e70245. [Abstract]
- Virus Genes. 2022 Apr;58(2):133-142. [Abstract]
- Eur J Oral Sci. 2025 Jan 8:e13034. [Abstract]
- Rev Bras Farmacogn. 2025 Sep 4.
- Dissolut Technol. 2020, 27(1):36-44.
- Int J Morphol. 40(5):1152-1164, 2022.
- Res Sq. 2026 Jun 15.
- bioRxiv. 2026 Mar 18.
- Res Sq. 2026 Feb 17.
- Res Sq. 2026 Jan 9.
- University of Otago. 2025 Oct 7.
- SSRN. 2025 Oct 14.
- bioRxiv. 2025 Aug 26.
- bioRxiv. 2025 Aug 25:2025.08.21.671520. [Abstract]
- SSRN. 2025 Jul 8.
- Res Sq. 2025 Jul 13.
- bioRxiv. 2025 May 31.
- bioRxiv. 2025 May 05.
- bioRxiv. 2025 March 21.
- bioRxiv. 2025 March 25.
- SSRN. 2025 Jan 31.
- Patent. US20240358802A1
- Patent. US20240358802A1.
- Res Sq. 2024 Jul 12.
- SSRN. 2024 May 30.
- Research Square Preprint. 2023 Jul 24.
- bioRxiv. 2023 May 12.
- SSRN. 2023 Feb 27.
- Research Square Print. November 29th, 2022.
- Research Square Print. 2022 Aug.
- Research Square Preprint. 2022 Jan.
- Ann Transl Med. 2021 Oct;9(20):1547. [Abstract]
- Patent. US20210128693A1.
- Research Square Preprint. 2020 Dec.
- Clinical Cancer Drugs. 2020 Apr.
-
RT-PCR
-
WB
-
WB
-
Cell Proliferation/Viability Assay
-
WB
All AMPK Isoforms
More
Biological Activity
|
AMPK |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
208 μM
Compound: Metformin
|
Antiproliferative activity against human A549 cells by IncuCyte live-cell imaging assay
Antiproliferative activity against human A549 cells by IncuCyte live-cell imaging assay
|
[PMID: 33103432] |
| HEK293 | IC50 |
1230 μM
Compound: Metformin
|
Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of MPP+ after 1 min
Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of MPP+ after 1 min
|
[PMID: 28230985] |
| HEK293 | IC50 |
250 μM
Compound: metformin
|
Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay
Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay
|
[PMID: 23241029] |
| HepG2 | EC50 |
0.27 μM
Compound: Metformin
|
Increase in glucose consumption in insulin-resistant human HepG2 cells after 24 hrs
Increase in glucose consumption in insulin-resistant human HepG2 cells after 24 hrs
|
[PMID: 21856048] |
| Hs-578T | IC50 |
26.8 mM
Compound: 6, metformin
|
Cytotoxicity against triple-negative human Hs578T cells assessed as growth inhibition after 24 hrs by MTT assay
Cytotoxicity against triple-negative human Hs578T cells assessed as growth inhibition after 24 hrs by MTT assay
|
[PMID: 23490148] |
| IGROV-1 | IC50 |
850 μM
Compound: Metformin (2)
|
Antiproliferative activity against human IGROV-1 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human IGROV-1 cells incubated for 72 hrs by MTT assay
|
[PMID: 33857729] |
| MCF7 | IC50 |
9.9 nM
Compound: 8
|
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 33479633] |
| MDA-MB-231 | IC50 |
58.4 mM
Compound: 6, metformin
|
Cytotoxicity against triple-negative human MDA-MB-231 cells assessed as growth inhibition after 24 hrs by MTT assay
Cytotoxicity against triple-negative human MDA-MB-231 cells assessed as growth inhibition after 24 hrs by MTT assay
|
[PMID: 23490148] |
| PC-3 | IC50 |
189 nM
Compound: 8
|
Cytotoxicity against human PC-3 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Cytotoxicity against human PC-3 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 33479633] |
| SK-OV-3 | IC50 |
150 μM
Compound: Metformin (2)
|
Antiproliferative activity against human SK-OV-3 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human SK-OV-3 cells incubated for 72 hrs by MTT assay
|
[PMID: 33857729] |
Metformin (1,1-Dimethylbiguanide) hydrochloride inhibits proliferation of ESCs in a concentration-dependent manner. The IC50 is 2.45 mM for A-ESCs and 7.87 mM for N-ESCs. Metformin hydrochloride shows pronounced effects on activation of AMPK signaling in A-ESCs from secretory phase than in cells from proliferative phase[3].
Metformin (0-500 μM) hydrochloride decreases glycogen synthesis in a dose-dependent manner with an IC50 value of 196.5 μM in cultured rat hepatocytes[4].
Metformin hydrochloride shows cell viability and cytotoxic effects on PC-3 cells with IC50 of 5 mM[5].
Metformin (1-50 mM; 0-120 h) hydrochloride significantly inhibites the proliferation of both 786-O and OS-RC-2 RCC cell lines in a dose- and time-dependent manner[7].
Metformin (5 mM; 0-48 h) glycinate stimulates AMPK and inhibited the mTOR signaling pathway in 786-O cells[7].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:786-O and OS-RC-2 cells
-
Concentration:1, 5, 10, 20 and 50 mM
-
Incubation Time:0-120 h
-
Result:Inhibited the growth of 786-O and OS-RC-2 cells by 10% and 14% at doses of 0.2 and 0.5 mM, respectively.
-
Cell Line:786-O cells
-
Concentration:5 mM
-
Incubation Time:0-48 h
-
Result:Reduced phosphorylation of S6K1 (Thr389) in a time-dependent manner, and thus reduced phosphorylation of ribosomal S6 protein (Ser235/236).
Activated AMPK in a time-dependent manner.
Metformin (> 900 mg/kg/day, p.o.) hydrochloride results in moribundity/mortality and clinical signs of toxicity in Crl:CD(SD) rats[2].
Metformin (200 mg/kg; i.p.; once a day for 6 consecutive days before induction of ischemia and at the beginning of reperfusion) hydrochloride significantly reduces the serum alanine aminotransferase (ALT) level in rats with ischemia-reperfusion model[6].
Metformin (250 mg/kg; i.p.; once daily for 22 days) hydrochloride significantly reduces the growth of 786-O cell xenograft tumors in nude mice[7].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 1115-70-4
-
Appearance Solid
-
Molecular Weight 165.62
-
Formula C4H12ClN5
-
Color White to off-white
-
SMILES
NC(NC(N(C)C)=N)=N.Cl
-
Synonyms
1,1-Dimethylbiguanide hydrochloride
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (199)
-
Journal Impact Factor
-
Most Recent
-
Signal Transduct Target Ther
Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis. [Abstract]2023 Mar 6;8(1):95. PMID: 36872368 -
Signal Transduct Target Ther
Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance. [Abstract]2020 May 20;5(1):56. PMID: 32433544 -
Nature
2025 Feb;638(8052):1112-1121. PMID: 39814884
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Nature. 2025 Feb;638(8052):1112-1121. [Abstract]
Metformin (2 mM; 16 h) significantly inhibits the mRNA expression of FOXM1 downstream genes (CDC25B, CCNA2) in HEK293T cells.
-
Nature
2023 Sep;621(7977):188-195. PMID: 37648854 -
Cancer Cell
SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways. [Abstract]2020 Sep 14;38(3):350-365.e7. PMID: 32619406 -
Circulation
Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries. [Abstract]2023 Jan 10;147(2):158-174. PMID: 36448459
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Circulation. 2023 Jan 10;147(2):158-174. [Abstract]
Metformin. Western blot analysis of CB2R in the heart from db/db diabetic (DM) mice at different ages.
-
Cell Metab
Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity. [Abstract]2023 Jul 11;35(7):1132-1146.e9. PMID: 37230079 -
Cell Metab
Discovery of a potent allosteric activator of DGKQ that ameliorates obesity-induced insulin resistance via the sn-1,2-DAG-PKCε signaling axis. [Abstract]2023 Jan 3;35(1):101-117.e11. PMID: 36525963 -
Adv Mater
2020 Nov;32(45):e2003708. PMID: 33015921 -
Cell Res
Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P. [Abstract]2023 Dec;33(12):904-922. PMID: 37460805
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Cell Res. 2023 Dec;33(12):904-922. [Abstract]
Cells were treated with mannose, MK-8722 (1 μM) or Metformin (1 mM) for 6 h. GSDME was immunoprecipitated using anti-GSDME antibody, and then the phosphorylation levels of GSDME T6 were detected.
-
Nat Metab
2025 Apr;7(4):730-741. PMID: 40114026 -
Cell Stem Cell
Kidney organoid models reveal cilium-autophagy metabolic axis as a therapeutic target for PKD both in vitro and in vivo. [Abstract]2024 Jan 4;31(1):52-70.e8. PMID: 38181751 -
Nat Commun
NEK7 couples SDHB to orchestrate respiratory chain electron transport homeostasis that impedes liver fibrosis. [Abstract]2025 Nov 28;16(1):10751. PMID: 41315267 -
Nat Commun
PD-L1 degradation is regulated by electrostatic membrane association of its cytoplasmic domain. [Abstract]2021 Aug 24;12(1):5106. PMID: 34429434 -
Nat Commun
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy. [Abstract]2019 Feb 6;10(1):620. PMID: 30728358 -
Cell Death Differ
GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis. [Abstract]2023 Jul;30(7):1829-1848. PMID: 37337032 -
Bone Res
Metformin accelerates bone fracture healing by promoting type H vessel formation through inhibition of YAP1/TAZ expression. [Abstract]2023 Aug 16;11(1):45. PMID: 37587136 -
Acta Pharm Sin B
2025 Dec;15(12):6382-6398. PMID: 41477334 -
Autophagy
Activation of chaperone-mediated autophagy suppresses glioblastoma by promoting wild-type IDH1/isocitrate dehydrogenase 1 degradation. [Abstract]2025 Nov 30:1-21. PMID: 41231102 -
Adv Sci (Weinh)
Single-Mitochondrion ATP Profiling Directs Discovery of Targetable OXPHOS Dependency in Cancers. [Abstract]2026 Apr;13(21):e13341. PMID: 41684301 -
J Adv Res
Discovery and identification of semaphorin 4D as a bioindicator of high fracture incidence in type 2 diabetic mice with glucose control. [Abstract]2025 Mar 10:S2090-1232(25)00174-2. PMID: 40073972
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: J Adv Res. 2025 Mar 10:S2090-1232(25)00174-2. [Abstract]
STAT3 levels in hBMSCs treated with metformin and the miR-140-3p inhibitor.
-
J Adv Res
Interplay between lipid dysregulation and ferroptosis in chondrocytes and the targeted therapy effect of metformin on osteoarthritis. [Abstract]2024 Apr 14:S2090-1232(24)00155-3. PMID: 38621621 -
Biomaterials
Microenvironment-engineered hydrogels drive osteo-angiogenic coupling to accelerate osteoporotic bone regeneration. [Abstract]2026 Jun:329:123966. PMID: 41520542 -
Biomaterials
Zn2+-driven metformin conjugated with siRNA attenuates osteoarthritis progression by inhibiting NF-κB signaling and activating autophagy. [Abstract]2025 Aug:319:123210. PMID: 40037209 -
Biomaterials
Metformin facilitates mesenchymal stem cell-derived extracellular nanovesicles release and optimizes therapeutic efficacy in intervertebral disc degeneration. [Abstract]2021 Jul:274:120850. PMID: 33984637 -
Exp Mol Med
AMPK alleviates high uric acid-induced Na+-K+-ATPase signaling impairment and cell injury in renal tubules. [Abstract]2019 May 22;51(5):1-14. PMID: 31118410 -
Protein Cell
Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer. [Abstract]2022 Nov;13(11):825-841. PMID: 35217990 -
J Nanobiotechnology
Biomimetic ferritin nanocages for synergistic co-delivery of metformin and rapamycin restore neurodevelopmental homeostasis in autism spectrum disorders. [Abstract]2025 Oct 14;23(1):670. PMID: 41083985 -
Sci Adv
Bacteriocin-transport-inspired oral peptide-probiotic delivery ameliorates IBD complications via autophagy and gut homeostasis. [Abstract]2026 Jan 2;12(1):eadz9069. PMID: 41481708 -
Sci Adv
Endogenous/exogenous dual-responsive nanozyme for photothermally enhanced ferroptosis-immune reciprocal synergistic tumor therapy. [Abstract]2025 May 16;11(20):eadq3870. PMID: 40367177 -
Redox Biol
Metformin inhibits methylglyoxal-induced retinal pigment epithelial cell death and retinopathy via AMPK-dependent mechanisms: Reversing mitochondrial dysfunction and upregulating glyoxalase 1. [Abstract]2023 Aug:64:102786. PMID: 37348156
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Redox Biol. 2023 Aug:64:102786. [Abstract]
Metformin hydrochloride (Metformin; 2, 6, 20 mM; 30 min) attenuates MGO-induced cell death in a concentration-dependent manner in ARPE-19 cells.
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Redox Biol. 2023 Aug:64:102786. [Abstract]
Metformin hydrochloride (Met; 3, 6 mM; 30 min) inhibits MGO-induced the increased expression of Bax and caspase-3 cleavage and decreased expression of Bcl-2 in ARPE-19 cells.
-
Cell Rep Med
Augment proteasome inhibitor efficacy activates CD8+ T cell-mediated antitumor immunity in breast cancer. [Abstract]2025 Jul 15;6(7):102211. PMID: 40609539 -
Cancer Lett
SLC5A11 mediates metformin-induced PD-L1 suppression to enhance cancer immunotherapy through AMPK-IRF1 signaling. [Abstract]2026 Apr 28:644:218311. PMID: 41690450 -
Cancer Lett
6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells. [Abstract]2024 Aug 21:217177. PMID: 39179096 -
Cancer Lett
Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization. [Abstract]2024 Apr 10:587:216732. PMID: 38360142 -
J Neuroinflammation
AMPK-autophagy-mediated inhibition of microRNA-30a-5p alleviates morphine tolerance via SOCS3-dependent neuroinflammation suppression. [Abstract]2022 Jan 29;19(1):25. PMID: 35093117 -
Cancer Lett
Metformin sensitizes AML cells to chemotherapy through blocking mitochondrial transfer from stromal cells to AML cells. [Abstract]2022 Apr 28:532:215582. PMID: 35122876 -
Cell Death Dis
Mitochondrial oxidative phosphorylation is dispensable for survival of CD34+ chronic myeloid leukemia stem and progenitor cells. [Abstract]2022 Apr 20;13(4):384. PMID: 35444236 -
Cell Death Dis
AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice. [Abstract]2021 Oct 9;12(10):925. PMID: 34628484 -
Cell Death Dis
Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase. [Abstract]2021 Oct 2;12(10):902. PMID: 34601503 -
-
-
Cell Commun Signal
Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy. [Abstract]2023 May 4;21(1):99. PMID: 37143083 -
Int J Biol Macromol
Bacterial cellulose membrane integrating phase-transited lysozyme nanofilm loaded with biguanides for dressing treatment of atopic dermatitis. [Abstract]2025 Aug 21;323(Pt 1):147047. PMID: 40848785 -
Acta Pharmacol Sin
Metformin promotes microglial cells to facilitate myelin debris clearance and accelerate nerve repairment after spinal cord injury. [Abstract]2022 Jun;43(6):1360-1371. PMID: 34480113 -
Phytomedicine
Eleutheroside B liposomes ameliorate type 2 diabetes mellitus by modulating glucose and lipid metabolism: A metabolomic study. [Abstract]2025 Nov 27:150:157628. PMID: 41330184 -
Phytomedicine
Lapagyl mitigates UV-induced inflammation and immunosuppression via Foxp3+ Tregs and CCL pathway: A single-cell transcriptomics study. [Abstract]2024 Jul:129:155679. PMID: 38701542 -
Free Radic Biol Med
p67phox/NOX2 inhibits psoriasis by regulating the HIF-1α-glycolysis axis via p53-AMPK in keratinocytes. [Abstract]2025 Sep:237:503-514. PMID: 40516795 -
Food Res Int
Tea drinking effectively improves symptoms of diabetes and prevents hepatorenal damage in mice. [Abstract]2025 Jun:211:116502. PMID: 40356150 -
Sci Total Environ
Mechanisms and targeted reversion/prevention of hepatic fibrosis caused by the non-hereditary toxicity of benzo(a)pyrene. [Abstract]2024 Feb 20:912:169496. PMID: 38135085 -
Brain Behav Immun
Microbial reconstitution reverses prenatal stress-induced cognitive impairment and synaptic deficits in rat offspring. [Abstract]2024 Jun 6:S0889-1591(24)00445-8. PMID: 38851306 -
Biomed Pharmacother
2024 Sep 6:179:117399. PMID: 39243433 -
Emerg Microbes Infect
2022 Dec;11(1):815-828. PMID: 35191819 -
Biomed Pharmacother
Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR/PI3K/AKT/m-TOR pathway. [Abstract]2019 Jul:115:108875. PMID: 31028998 -
Chin Med J (Engl)
2025 Jun 16. PMID: 40518567 -
Stem Cell Res Ther
The role of PKM2-mediated metabolic reprogramming in the osteogenic differentiation of BMSCs under diabetic periodontitis conditions. [Abstract]2025 Apr 18;16(1):186. PMID: 40251642 -
Stem Cell Res Ther
2025 Jan 23;16(1):20. PMID: 39849625 -
PLoS Biol
The cell cycle regulator PLK1 promotes murine melanoma progression by regulating the transcription factor BACH1. [Abstract]2025 Nov 24;23(11):e3003490. PMID: 41284701 -
-
Cell Rep
circPRKAA1 activates a Ku80/Ku70/SREBP-1 axis driving de novo fatty acid synthesis in cancer cells. [Abstract]2022 Nov 22;41(8):111707. PMID: 36417875 -
-
Arch Toxicol
Upregulation of phosphoinositide 3-kinase prevents sunitinib-induced cardiotoxicity in vitro and in vivo. [Abstract]2019 Jun;93(6):1697-1712. PMID: 31025080 -
J Med Chem
Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes. [Abstract]2022 Sep 8;65(17):11818-11839. PMID: 36037148 -
Anal Chem
Noninvasive Dynamic Cell Viability Monitoring Based on Diffraction Height Fingerprint Spectra. [Abstract]2025 Dec 19. PMID: 41417584 -
Antioxidants
Different Effects of Metformin and A769662 on Sodium Iodate-Induced Cytotoxicity in Retinal Pigment Epithelial Cells: Distinct Actions on Mitochondrial Fission and Respiration. [Abstract]2020 Oct 28;9(11):1057. PMID: 33126710 -
-
Phytother Res
The combination of berberine and isoliquiritigenin synergistically improved adipose inflammation and obesity-induced insulin resistance. [Abstract]2024 May 10. PMID: 38729776 -
Cell Mol Life Sci
Metformin induces tolerogenicity of dendritic cells by promoting metabolic reprogramming. [Abstract]2023 Sep 9;80(10):283. PMID: 37688662 -
EMBO Rep
Developmental arsenic exposure impairs cognition, directly targets DNMT3A, and reduces DNA methylation. [Abstract]2022 Jun 7;23(6):e54147. PMID: 35373418 -
Hum Reprod
Metformin inhibits testosterone-induced endoplasmic reticulum stress in ovarian granulosa cells via inactivation of p38 MAPK. [Abstract]2020 May 1;35(5):1145-1158. PMID: 32372097 -
Cancer Cell Int
Icariin exerts anti-tumor activity by inducing autophagy via AMPK/mTOR/ULK1 pathway in triple-negative breast cancer. [Abstract]2024 Feb 14;24(1):74. PMID: 38355608 -
Front Immunol
ATP-Induced Inflammasome Activation and Pyroptosis Is Regulated by AMP-Activated Protein Kinase in Macrophages. [Abstract]2016 Dec 12:7:597. PMID: 28018360
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Front Immunol. 2016 Dec 12:7:597. [Abstract]
Metformin increases adenosine triphosphate-induced inflammasome activation in bone marrow-derived macrophages. (A) Cells are treated. Indicated protein levels in both cell lysates and supernatants are evaluated by western blotting. β-Tubulin is used as a loading control for cell lysates. (B–D) The quantitative analyses of the active caspase-1p10 (B), mature interleukin-1β (C), and HMGB1 (D) levels in the supernatants (A) are shown.
-
Chin Med
Berberine ameliorates high-fat diet-induced metabolic disorders through promoting gut Akkermansia and modulating bile acid metabolism. [Abstract]2025 Nov 17;20(1):190. PMID: 41243097 -
Biochem Pharmacol
Crizotinib induces pulmonary toxicity by blocking autophagy flux in alveolar epithelial cells. [Abstract]2023 Sep:215:115636. PMID: 37290598 -
Biochem Pharmacol
Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase. [Abstract]2017 Aug 15:138:49-60. PMID: 28528695
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Biochem Pharmacol. 2017 Aug 15:138:49-60. [Abstract]
PP5 overexpression suppresses AMPK-Thr172 phosphorylation induced by AMPK activators, AICAR and metformin. Hep3B cells are transfected with indicated plasmids and treated with AICAR (2 mM; 3 h) or Metformin (3 mM; 16 h) to simulate AMPK phosphorylation.
-
Mol Cell Proteomics
The Landscape of Histone Modifications in a High-Fat Diet-Induced Obese (DIO) Mouse Model. [Abstract]2017 Jul;16(7):1324-1334. PMID: 28450421
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Mol Cell Proteomics. 2017 Jul;16(7):1324-1334. [Abstract]
To further validate the MS quantification results, Western blot analysis is carried out using an anti-H3K36 dimethylation antibody. Consistent with the mass spectrometric data, H3K36 dimethylation was elevated in DIO mouse livers, whereas Metformin treatment can significantly decrease histone H3K36 dimethylation in DIO mice to a level close to that of the chow-fed control mice.
-
J Ethnopharmacol
Shentong Zhuyu Decoction mitigates exercise-induced muscle damage through modulation of AMPK-mediated lipid metabolism and oxidative stress. [Abstract]2026 Feb 28:357:120941. PMID: 41270908 -
Liver Int
Metformin synergistically enhances the antitumour activity of Lenvatinib in hepatocellular carcinoma by altering AKT-FOXO3 signalling pathway. [Abstract]2023 Jul;43(7):1577-1592. PMID: 37208925 -
Mech Ageing Dev
AMPK alleviates oxidative stress‑induced premature senescence via inhibition of NF-κB/STAT3 axis-mediated positive feedback loop. [Abstract]2020 Oct;191:111347. PMID: 32882228 -
Life Sci
Therapy of empagliflozin plus metformin on T2DM mice shows no higher amelioration for glucose and lipid metabolism than empagliflozin monotherapy. [Abstract]2019 Sep 1:232:116622. PMID: 31271767 -
Biofactors
Metformin and thymoquinone co-treatment enhance 5-fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells. [Abstract]2023 Jul-Aug;49(4):831-848. PMID: 36929658 -
PLoS Pathog
PoRVA G9P[23] and G5P[7] infections differentially promote PEDV replication by reprogramming glutamine metabolism. [Abstract]2024 Jun 21;20(6):e1012305. PMID: 38905309 -
PLoS Pathog
Picornavirus infection enhances aspartate by the SLC38A8 transporter to promote viral replication. [Abstract]2023 Feb 3;19(2):e1011126. PMID: 36735752 -
Int J Mol Sci
Metformin Alleviates Epirubicin-Induced Endothelial Impairment by Restoring Mitochondrial Homeostasis. [Abstract]2022 Dec 25;24(1):343. PMID: 36613786 -
Biomolecules
Mechanism of Mitophagy to Protect Yak Kidney from Hypoxia-Induced Fibrosis Damage by Regulating Ferroptosis Pathway. [Abstract]2025 Apr 9;15(4):556. PMID: 40305351 -
Pharmaceuticals (Basel)
2024 Sep 19;17(9):1234. PMID: 39338396 -
Front Bioeng Biotechnol
Application of 3D Hepatic Plate-Like Liver Model for Statin-Induced Hepatotoxicity Evaluation. [Abstract]2022 Mar 17;10:826093. PMID: 35372314 -
Biomolecules
2022 Mar 9;12(3):422. PMID: 35327614 -
Front Pharmacol
Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats via Activating AMPK/Nrf2 Signaling Pathway. [Abstract]2020 Jul 31;11:1038. PMID: 32903813 -
Front Pharmacol
Piperine Suppresses Pyroptosis and Interleukin-1β Release upon ATP Triggering and Bacterial Infection. [Abstract]2016 Oct 20:7:390. PMID: 27812336
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Front Pharmacol. 2016 Oct 20:7:390. [Abstract]
Metformin, an AMPK agonist, counteracts the effect of Piperine on suppressing ATP-induced AMPK activation and inflammatory mediator release. J774A.1 cells are pre-treated with 80 μM Piperine and BMDMs are pre-treated with 160 μM Piperine for 4 h. Without being washed out of Piperine, these cells are primed with LPS (500 ng/mL) for 4 h. Next, the cells are treated with Metformin (1 mM) for 1 h (in the absence of Piperine and LPS). Finally, in the presence of Metformin, the BMDMs are stimulated wi
-
Eur J Pharmacol
Novel mechanisms of metformin-induced vasorelaxation of mesenteric arterioles via endothelium-dependent hyperpolarization to treat murine colitis. [Abstract]2025 Sep 15:1003:177900. PMID: 40617384 -
Int Immunopharmacol
Metformin alleviates inflammatory responses in acute allergic asthma by inhibiting ILC2s function. [Abstract]2025 May 20:159:114897. PMID: 40398255 -
Am J Physiol Cell Physiol
Metformin Mitigates Adipogenesis of Fibro-adipogenic Progenitors After Rotator Cuff Tears Via Activating mTOR/ULK1 Mediated Autophagy. [Abstract]2024 Jun 1;326(6):C1590-C1603. PMID: 38586878 -
Int Immunopharmacol
Boningmycin induces AMPK-mediated endoplasmic reticulum-associated degradation of PD-L1 protein in human cancer cells. [Abstract]2023 Sep 15;124(Pt A):110905. PMID: 37717372 -
Eur J Pharmacol
Alisol B blocks the development of HFD-induced obesity by triggering the LKB1-AMPK signaling in subcutaneous adipose tissue. [Abstract]2023 Oct 5:956:175942. PMID: 37536624 -
Eur J Pharmacol
Idebenone attenuates ferroptosis by inhibiting excessive autophagy via the ROS-AMPK-mTOR pathway to preserve cardiac function after myocardial infarction. [Abstract]2023 Mar 15:943:175569. PMID: 36740037 -
Cell Regen
Cross-species single-cell transcriptomic analysis reveals divergence of cell composition and functions in mammalian ileum epithelium. [Abstract]2022 May 5;11(1):19. PMID: 35511361 -
Neuropharmacology
Hyperactive Akt-mTOR pathway as a therapeutic target for pain hypersensitivity in Cntnap2-deficient mice. [Abstract]2020 Mar 15;165:107816. PMID: 31874168 -
Mol Oncol
Loss of AMPK activation promotes the invasion and metastasis of pancreatic cancer through an HSF1-dependent pathway. [Abstract]2017 Oct;11(10):1475-1492. PMID: 28783244
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Mol Oncol. 2017 Oct;11(10):1475-1492. [Abstract]
MiaPaCa-2 cells are treated with a gradient concentration of Metformin for 24 h, and then, western blotting is performed to show the activation of p-AMPK and the suppression of HSF1 and HSP70.
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Mol Oncol. 2017 Oct;11(10):1475-1492. [Abstract]
(A) IHC staining of N-cadherin and E-cadherin in the pancreas from KPC mice treated with vehicle, Metformin, or KRIBB11. (B) Masson's trichrome staining and IHC staining of α-SMA in pancreatic tissues from mice treated with vehicle, Metformin, or KRIBB11.
-
Mol Oncol
Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner. [Abstract]2017 Aug;11(8):1035-1049. PMID: 28453226
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Mol Oncol. 2017 Aug;11(8):1035-1049. [Abstract]
Co-treatment of Metformin and Ribociclib induces cell death in Hep3B cells. Cells are exposed to Ribociclib at 25 μM and/or Metformin at 10 mM for 72 h.
-
Cancers (Basel)
Divergent Role of ULK1 to Balance Mitochondrial Homeostasis and Bioenergetics in Ovarian Cancer Spheroids. [Abstract]2026 May 27;18(11):1746. PMID: 42279329 -
Probiotics Antimicrob Proteins
Potential Benefits of Metformin Via Roseburia Intestinalis in High-fat Diet-fed Mice With Colorectal Adenomas. [Abstract]2025 Nov 26. PMID: 41296177 -
Rheumatology (Oxford)
Metformin attenuates osteoarthritis by targeting chondrocytes, synovial macrophages and adipocytes. [Abstract]2023 Apr 3;62(4):1652-1661. PMID: 35984286 -
Cancers (Basel)
In Vivo and In Vitro Enhanced Tumoricidal Effects of Metformin, Active Vitamin D3, and 5-Fluorouracil Triple Therapy against Colon Cancer by Modulating the PI3K/Akt/PTEN/mTOR Network. [Abstract]2022 Mar 17;14(6):1538. PMID: 35326689 -
Cancers (Basel)
Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma. [Abstract]2021 Aug 6;13(16):3978. PMID: 34439134 -
Transl Stroke Res
Metformin Alleviates Delayed Hydrocephalus after Intraventricular Hemorrhage by Inhibiting Inflammation and Fibrosis. [Abstract]2023 Jun;14(3):364-382. PMID: 35852765 -
Mol Neurobiol
Metformin Improves Functional Recovery After Spinal Cord Injury via Autophagy Flux Stimulation. [Abstract]2017 Jul;54(5):3327-3341. PMID: 27167128
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Mol Neurobiol. 2017 Jul;54(5):3327-3341. [Abstract]
Met attenuates apoptosis caused by traumatic spinal cord injury in rat. a, b Representative western blots and quantification data of cleaved caspase 3 and β-actin in each group rats. c, d Representative western blots and quantification data of Bax, Bcl-2, and β-actin in each group rats.
-
J Cell Mol Med
Sodium (±)-5-bromo-2-(α-hydroxypentyl) benzoate ameliorates pressure overload-induced cardiac hypertrophy and dysfunction through inhibiting autophagy. [Abstract]2019 Sep;23(9):6048-6059. PMID: 31222939 -
J Cell Mol Med
Metformin ameliorates BSCB disruption by inhibiting neutrophil infiltration and MMP-9 expression but not direct TJ proteins expression regulation. [Abstract]2017 Dec;21(12):3322-3336. PMID: 28699677
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: J Cell Mol Med. 2017 Dec;21(12):3322-3336. [Abstract]
Metformin prevents the loss of tight junction (TJ) proteins after SCI. Representative Western blots and quantification data of Occludin, Claudin-5, ZO-1 and β-actin at 3 day after injury.
-
iScience
2026 Jun 13;29(7):116323. PMID: 42325565 -
J Inflamm Res
Metformin Attenuates Osteoarthritis Progression by Modulating Mitochondrial Dynamics via Activation of the AMPK/Drp1 Pathway. [Abstract]2026 Feb 2:19:540176. PMID: 41884158 -
J Inflamm Res
Combining Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and Experimental Validation to Uncover the Efficacy and Mechanisms of Si-Miao-Yong-An Decoction in Diabetic Wound Healing. [Abstract]2025 Mar 19:18:4087-4101. PMID: 40129870 -
iScience
2025 Apr 3;28(5):112344. PMID: 40276762 -
J Inflamm (Lond)
Emodin alleviates intestinal ischemia-reperfusion injury through antioxidant stress, anti-inflammatory responses and anti-apoptosis effects via Akt-mediated HO-1 upregulation. [Abstract]2024 Jul 9;21(1):25. PMID: 38982499 -
iScience
Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes. [Abstract]2023 Jan 25;26(4):106057. PMID: 36942050 -
J Cell Physiol
Mitochondrial and Glucose Metabolic Patterns in Pre-Granulosa Cells and Oocytes and Their Dysfunctions Induce Impaired Primordial Follicle Formation in Mice. [Abstract]2025 Nov;240(11):e70110. PMID: 41251108 -
J Drug Target
Dual AMPK activation and TXNIP suppression underlie the superior anti-diabetic action of rosiglitazone-metformin co-crystal (RZM): evidence from preclinical models. [Abstract]2025 Jul 17:1-10. PMID: 40658109 -
Sci Rep
2025 Jul 26;15(1):27294. PMID: 40715275 -
Sci Rep
Lethal toxicity of metformin on zebrafish during early embryonic development by multi-omics analysis. [Abstract]2025 Apr 2;15(1):11309. PMID: 40175592 -
Biomedicines
Metformin Inhibited GSDME to Suppress M2 Macrophage Pyroptosis and Maintain M2 Phenotype to Mitigate Cisplatin-Induced Intestinal Inflammation. [Abstract]2024 Nov 4;12(11):2526. PMID: 39595093 -
-
J Biol Chem
Autolysosomal degradation of cytosolic chromatin fragments antagonizes oxidative stress-induced senescence. [Abstract]2020 Apr 3;295(14):4451-4463. PMID: 32047109 -
J Virol
2025 Aug 29:e0052925. PMID: 40879372 -
Cell Signal
AMPK-mediated autophagy pathway activation promotes ΔFosB degradation to improve levodopa-induced dyskinesia. [Abstract]2024 Jun:118:111125. PMID: 38432574 -
Brain Res Bull
Delayed metformin treatment improves functional recovery following traumatic brain injury via central AMPK-dependent brain tissue repair. [Abstract]2020 Nov;164:146-156. PMID: 32858129 -
Bone
The protection of nicotinamide riboside against diabetes mellitus-induced bone loss via OXPHOS. [Abstract]2025 Jan 28:193:117411. PMID: 39884488 -
Mol Cell Endocrinol
Metformin inhibits cell proliferation and ACTH secretion in AtT20 cells via regulating the MAPK pathway. [Abstract]2024 Mar 1:582:112140. PMID: 38147953 -
Exp Cell Res
NOP14 promotes proliferative diabetic retinopathy through ribosome biogenesis and endothelial dysfunction via Wnt/β-catenin signaling activation. [Abstract]2026 Apr 1;457(1):114922. PMID: 41638389 -
Mol Med Rep
Triptolide promotes ferroptosis by suppressing Nrf2 to overcome leukemia cell resistance to doxorubicin. [Abstract]2023 Jan;27(1):17. PMID: 36453238 -
Spine
AMP-Activated Protein Kinase Activation in Dorsal Root Ganglion Suppresses mTOR/p70S6K Signaling and Alleviates Painful Radiculopathies in Lumbar Disc Herniation Rat Model. [Abstract]2019 Aug 1;44(15):E865-E872. PMID: 30817738 -
Acta Biochim Biophys Sin (Shanghai)
2021 Mar 2;53(3):333-341. PMID: 33522578 -
Andrology
In vitro exposure to metformin activates human spermatozoa at therapeutically relevant concentrations. [Abstract]2020 May;8(3):663-670. PMID: 31944615 -
Appl Biochem Biotechnol
Knocking Down CDKN2A Enhances the Therapeutic Effects of Metformin and Resveratrol on Diabetic Retinopathy. [Abstract]2026 Mar 17. PMID: 41843007 -
-
Biochim Biophys Acta Mol Cell Biol Lipids
Oroxylin A ameliorates non-alcoholic fatty liver disease by modulating oxidative stress and ferroptosis through the Nrf2 pathway. [Abstract]2025 May 12:159628. PMID: 40368273 -
Front Oncol
Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Catrcinoma by Inhibiting IL-6 Signaling Pathway. [Abstract]2021 Nov 22;11:762523. PMID: 34881181 -
Pathogens
Proteomic Discovery of VEEV E2-Host Partner Interactions Identifies GRP78 Inhibitor HA15 as a Potential Therapeutic for Alphavirus Infections. [Abstract]2021 Mar 2;10(3):283. PMID: 33801554 -
Endocrinology
miR-1224-5p Enhances Hepatic Lipogenesis by Targeting Adenosine Monophosphate-Activated Protein Kinase α1 in Male Mice. [Abstract]2018 May 1;159(5):2008-2021. PMID: 29474539
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Endocrinology. 2018 May 1;159(5):2008-2021. [Abstract]
Male C57BL/6 mice are intragastrically treated with Metformin or placebo at 3 mg/kg/day for 10 weeks in the presence of HFD after 10-week-HFD feeding and then sacrificed for sample collection. Western blot analysis of AMPKα1, AMPK, p-AMPK, SREBP1 and FAS.
-
Environ Toxicol
Metformin and chidamide synergistically suppress multiple myeloma progression and enhance lenalidomide/bortezomib sensitivity. [Abstract]2024 Apr;39(4):2452-2465. PMID: 38251764 -
Environ Toxicol
Pretreatment with metformin prevents microcystin-LR-induced tau hyperphosphorylation via mTOR-dependent PP2A and GSK-3β activation. [Abstract]2021 Dec;36(12):2414-2425. PMID: 34432352 -
Naunyn Schmiedebergs Arch Pharmacol
Protective effect of orientin on diabetic nephropathy in rat models of high-fat diet and streptozotocin-induced diabetes. [Abstract]2025 Mar 4. PMID: 40035824 -
J Neuropathol Exp Neurol
Downregulating Cdk5 reverses hippocampal neuron ferroptosis by regulating the AMP-activated protein kinase pathway and "M1" polarized microglia. [Abstract]2025 Aug 19:nlaf092. PMID: 40829042 -
Curr Issues Mol Biol
Gypenosides Alleviate Hyperglycemia by Regulating Gut Microbiota Metabolites and Intestinal Permeability. [Abstract]2025 Jul 3;47(7):515. PMID: 40728984 -
Breast Cancer Res Treat
2025 Jun;211(2):467-478. PMID: 40055251 -
Mol Reprod Dev
Effect of berberine combined with metformin on autophagy in polycystic ovary syndrome by regulating AMPK/AKT/mTOR pathway. [Abstract]2024 Aug;91(8):e23768. PMID: 39155689 -
Arch Biochem Biophys
FAM98A promotes resistance to 5-fluorouracil in colorectal cancer by suppressing ferroptosis. [Abstract]2022 Jun 15;722:109216. PMID: 35421356 -
Oral Dis
Metformin overcomes chemoresistance by regulating stemness via KLF4 in oral squamous cell carcinoma. [Abstract]2025 Feb;31(2):468-481. PMID: 39039738 -
J Appl Toxicol
Capacitation-Induced Changes in Sperm Motility, AMPK Phosphorylation, and Tyrosine Phosphorylation Are Diminished by Therapeutically Relevant Concentrations of Metformin. [Abstract]2026 Feb 2. PMID: 41628886 -
Neuroscience
Protective effects of PIK3CG knockdown against OGD/R-induced neuronal damage via inhibition of autophagy through the AMPK/mTOR pathway. [Abstract]2025 Jan 26:565:91-98. PMID: 39603405 -
J Chromatogr B Analyt Technol Biomed Life Sci
Integrated HPLC, pharmacodynamics, and immunoprofiling to explore active components and mechanism of Zhi Bai Heye Fang on glycolipid metabolic disorders in mice. [Abstract]2024 Dec 28:1252:124446. PMID: 39754817 -
J Orthop Surg Res
Molecular mechanisms of AMPK/YAP/NLRP3 signaling pathway affecting the occurrence and development of ankylosing spondylitis. [Abstract]2023 Nov 4;18(1):831. PMID: 37925428 -
Genes (Basel)
2022 Dec 16;13(12):2384. PMID: 36553651 -
Onco Targets Ther
2020 May 4;13:3777-3788. PMID: 32440146 -
Onco Targets Ther
Metformin Promotes Beclin1-Dependent Autophagy to Inhibit the Progression of Gastric Cancer. [Abstract]2020 May 19;13:4445-4455. PMID: 32547075 -
Virus Res
Porcine reproductive and respiratory syndrome virus regulates lipid droplet accumulation in lipid metabolic pathways to promote viral replication. [Abstract]2023 Aug:333:199139. PMID: 37217033 -
PLoS One
Development of a cell-free screening assay for the identification of direct PERK activators. [Abstract]2023 May 18;18(5):e0283943. PMID: 37200357 -
Cell Biochem Biophys
Metformin Inhibits the Development of Helicobacter pylori-Associated Gastritis by Regulating the ERK-MMP10-IL-1β Axis. [Abstract]2025 Apr 4. PMID: 40180700 -
Oncol Lett
Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR/HIF-1α/PKM2/STAT3 pathway. [Abstract]2021 Jan;21(1):31. PMID: 33262823 -
Biochem Bioph Res Co
Combination of metformin and RG7388 enhances inhibition of growth and induction of apoptosis of ovarian cancer cells through the PI3K/AKT/mTOR pathway. [Abstract]2020 Dec 17;533(4):665-671. PMID: 33051060 -
Biochem Cell Biol
NDUFA4 promotes the progression of head and neck paraganglioma by inhibiting ferroptosis. [Abstract]2023 Dec 1;101(6):523-530. PMID: 37602474 -
Physiol Res
Dose-Dependent Impact of Metformin on Osteoblast-Specific Biomarkers in Cultured Rat Primary Osteoblasts. [Abstract]2026 Mar 13;75(1):187-192. PMID: 41823098 -
Stem Cells Dev
Metformin Rescues the Impaired Osteogenesis Differentiation Ability of Rat Adipose-Derived Stem Cells in High Glucose by Activating Autophagy. [Abstract]2021 Oct 15;30(20):1017-1027. PMID: 34486387 -
Cell Physiol Biochem
Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking. [Abstract]2018;51(4):1566-1583. PMID: 30497066 -
Cell Physiol Biochem
Isogambogenic Acid Inhibits the Growth of Glioma Through Activation of the AMPK-mTOR Pathway. [Abstract]2017;44(4):1381-1395. PMID: 29186708
Metformin hydrochloride purchased from MedChemExpress. Usage Cited in: Cell Physiol Biochem. 2017;44(4):1381-1395. [Abstract]
U87 cells are treated with Met alone or in the presence of isogambogenic acid for 24 h. The expression levels of phosphorylated AMPK, mTOR and 4E-BP1 are assessed by western blotting, with total AMPK, mTOR and 4E-BP1 used as the internal controls.
-
Cancer Rep (Hoboken)
Identification of Androgen Receptor as a Molecular Docking Target for Survival and Response to Metformin-Induced Ferroptosis in Liver Cancer. [Abstract]2025 Jul;8(7):e70245. PMID: 40583627 -
Virus Genes
AMP-activated kinase regulates porcine reproductive and respiratory syndrome virus infection in vitro. [Abstract]2022 Apr;58(2):133-142. PMID: 35254586 -
Eur J Oral Sci
Efficacy of metformin and verteporfin treatment alone or in combination in a murine head and neck cancer xenograft model. [Abstract]2025 Jan 8:e13034. PMID: 39780329 -
-
-
-
-
-
-
-
-
-
-
bioRxiv
2025 Aug 25:2025.08.21.671520. PMID: 40909720 -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Ann Transl Med
Metformin alleviates bevacizumab-induced vascular endothelial injury by up-regulating GDF15 and activating the PI3K/AKT/FOXO/PPARγ signaling pathway. [Abstract]2021 Oct;9(20):1547. PMID: 34790753 -
-
-
Solvent & Solubility
H2O : ≥ 100 mg/mL (603.79 mM)
DMSO : ≥ 1.7 mg/mL (10.26 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: PBS
Solubility: 100 mg/mL (603.79 mM); Clear solution; Need ultrasonic
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
Purity & Documentation
-
Data Sheet (278 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Soraya H, et al. Acute treatment with metformin improves cardiac function following NSC 37745 induced myocardial infarction in rats. Pharmacol Rep. 2012;64(6):1476-84. [Content Brief]
[2]. Quaile MP, et al. Toxicity and toxicokinetics of metformin in rats. Toxicol Appl Pharmacol. 2010 Mar 15;243(3):340-7. [Content Brief]
[3]. Xue J, et al. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis. Reproduction. 2013 Aug 21;146(4):397-406. [Content Brief]
[4]. Otto M, et al. Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes. Diabetes Obes Metab. 2003 May;5(3):189-94. [Content Brief]
[5]. Avci CB, et al. Therapeutic potential of an anti-diabetic drug, metformin: alteration of miRNA expression in prostate cancer cells. Asian Pac J Cancer Prev. 2013;14(2):765-8. [Content Brief]
[6]. Abdel-Zaher AO, et al. Novel mechanistic insights of the potential role of gasotransmitters and autophagy in the protective effect of metformin against hepatic ischemia/reperfusion injury in rats. Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 6. [Content Brief]
[7]. Liu J, et al. Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft. Urol Oncol. 2013 Feb;31(2):264-70. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO / H2O | 1 mM | 6.0379 mL | 30.1896 mL | 60.3792 mL | 150.9480 mL |
| 5 mM | 1.2076 mL | 6.0379 mL | 12.0758 mL | 30.1896 mL | |
| 10 mM | 0.6038 mL | 3.0190 mL | 6.0379 mL | 15.0948 mL | |
| H2O | 15 mM | 0.4025 mL | 2.0126 mL | 4.0253 mL | 10.0632 mL |
| 20 mM | 0.3019 mL | 1.5095 mL | 3.0190 mL | 7.5474 mL | |
| 25 mM | 0.2415 mL | 1.2076 mL | 2.4152 mL | 6.0379 mL | |
| 30 mM | 0.2013 mL | 1.0063 mL | 2.0126 mL | 5.0316 mL | |
| 40 mM | 0.1509 mL | 0.7547 mL | 1.5095 mL | 3.7737 mL | |
| 50 mM | 0.1208 mL | 0.6038 mL | 1.2076 mL | 3.0190 mL | |
| 60 mM | 0.1006 mL | 0.5032 mL | 1.0063 mL | 2.5158 mL | |
| 80 mM | 0.0755 mL | 0.3774 mL | 0.7547 mL | 1.8868 mL | |
| 100 mM | 0.0604 mL | 0.3019 mL | 0.6038 mL | 1.5095 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.